You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 253 No. 2, January 11, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Screening Test for HTLV-III (AIDS Agent) Antibodies

Specificity, Sensitivity, and Applications

Stanley H. Weiss, MD; James J. Goedert, MD; M. G. Sarngadharan, PhD; Anne J. Bodner, PhD; The AIDS Seroepidemiology Collaborative Working Group; Robert C. Gallo, MD; William A. Blattner, MD

JAMA. 1985;253(2):221-225.


Abstract

The third member of the human T-cell leukemia (lymphotrophic) retrovirus family (HTLV-III) is a newly discovered retrovirus that has been closely associated with the acquired immunodeficiency syndrome (AIDS). In our application of an enzyme-linked immunosorbent assay (ELISA) for HTLV-III antibodies, 72 (82%) of 88 patients with AIDS were positive, 14 (16%) were borderline, and two (2%) were negative. In contrast, only 1% of 297 volunteer blood donors were positive, 6% were borderline, and 93% were negative, demonstrating that this ELISA for HTLV-III antibodies is highly specific and sensitive for AIDS (excluding borderline results, 98.6% and 97.3%, respectively). Among persons at high risk for AIDS, 8% had borderline results, with positive and negative results readily distinguished as bimodal distributions that paralleled the temporal and geographic trends in AIDS. None of the 188 laboratory and health care employees working with patients with AIDS or their specimens were positive for HTLV-III antibodies, indicating that current precautions for health care workers appear adequate. This ELISA for HTLV-III antibodies will be a useful screening test among blood donors and populations at risk for AIDS, will aid in the diagnosis of suspected AIDS, and will help in defining the spectrum of diseases that are etiologically related to HTLV-III.

(JAMA 1985;253:221-225)



Author Affiliations

From the Environmental Epidemiology Branch, Division of Cancer Etiology (Drs Weiss, Goedert, Blattner, Biggar, Clark, Greene, and Winn), the Medicine Branch (Dr Gelmann) and Laboratory of Tumor Cell Biology, Division of Cancer Treatment (Drs Gallo, Popovic, Robert-Guroff, and Saxinger), National Cancer Institute, Bethesda, Md; Biotech Research Laboratories Inc, Rockville, Md (Dr Bodner); Department of Cell Biology, Litton Bionetics Inc, Kensington, Md (Dr Sarngadharan); Flushing Hospital, Flushing, NY (Dr Giron); American Red Cross Blood Services Laboratories, Bethesda, Md (Dr Dodd); Institute of Cancer Research, Aarhus, Denmark (Dr Melbye); and the Department of Infectious Disease, New York Veterans Administration Medical Center, New York (Dr Simberkoff).


Footnotes

Reprint requests to Environmental Epidemiology Branch, Landow Bldg, Room 3C19, National Cancer Institute, Bethesda, MD 20205 (Dr Weiss).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Detection of HIV-1 RNA by nucleic acid sequence-based amplification combined with fluorescence correlation spectroscopy
Oehlenschlager et al.
Proc. Natl. Acad. Sci. USA 1996;93:12811-12816.
ABSTRACT | FULL TEXT  

Risk Factors for Repeatedly Reactive HIV-1 EIA and Indeterminate Western Blots: A Population-Based Case-Control Study
Celum et al.
Arch Intern Med 1994;154:1129-1137.
ABSTRACT  

Classifying Binormal Diagnostic Tests Using Separation - Asymmetry Diagrams with Constant-performance Curves
Somoza
Med Decis Making 1994;14:157-168.
ABSTRACT  

Links Between Cocaine and Retroviral Infection
Weiss
JAMA 1989;261:607-609.
ABSTRACT  

False-Positive Tests for Human Immunodeficiency Virus (HIV) in Patients with Cystic Fibrosis
Dillman et al.
ANN INTERN MED 1989;110:94-94.
ABSTRACT  

Cystic Parotid Lesions in Patients at Risk for the Acquired Immunodeficiency Syndrome
Finfer et al.
Arch Otolaryngol Head Neck Surg 1988;114:1290-1294.
ABSTRACT  

Human Immunodeficiency Virus Test Evaluation, Performance, and Use: Proposals to Make Good Tests Better
Schwartz et al.
JAMA 1988;259:2574-2579.
ABSTRACT  

Human Immunodeficiency Virus Antibody Testing: A Description of Practices and Policies at US Infectious Disease--Teaching Hospitals and Minnesota Hospitals
Henry et al.
JAMA 1988;259:1819-1822.
ABSTRACT  

Analysis of the Use of HIV Antibody Testing in a Minnesota Hospital
Henry et al.
JAMA 1988;259:229-232.
ABSTRACT  

Use and Interpretation of Diagnostic Immunologic Laboratory Tests
deShazo et al.
JAMA 1987;258:3011-3031.
ABSTRACT  

Transmission of HTLV-I and HIV Among Homosexual Men in Trinidad
Bartholomew et al.
JAMA 1987;257:2604-2608.
ABSTRACT  

The Prevention of Acquired Immunodeficiency Syndrome in the United States: An Objective Strategy for Medicine, Public Health, Business, and the Community
Francis and Chin
JAMA 1987;257:1357-1366.
ABSTRACT  

Effect of T4 Count and Cofactors on the Incidence of AIDS in Homosexual Men Infected With Human Immunodeficiency Virus
Goedert et al.
JAMA 1987;257:331-334.
ABSTRACT  

National Surveillance of AIDS in Health Care Workers
Lifson et al.
JAMA 1986;256:3231-3234.
ABSTRACT  

HIV Seroprevalence Among Hospital Workers in Kinshasa, Zaire: Lack of Association With Occupational Exposure
Mann et al.
JAMA 1986;256:3099-3102.
ABSTRACT  

The Epidemiology of the Human Immunodeficiency Virus Infection
Mueller
J Law Med Ethics 1986;14:250-258.
 

Intravenous Drug Abusers and HIV Infections: A Consequence of Their Actions
Ginzburg
J Law Med Ethics 1986;14:268-272.
 

Possible Female-to-Female Transmission of Human Immunodeficiency Virus
MARMOR et al.
ANN INTERN MED 1986;105:969-969.
ABSTRACT  

Streptococcus mitis Endocarditis: Report of 17 Cases
Rapeport et al.
Arch Intern Med 1986;146:2361-2363.
ABSTRACT  

HIV Antibody Screening: An Ethical Framework for Evaluating Proposed Programs
Bayer et al.
JAMA 1986;256:1768-1774.
ABSTRACT  

Testing for Human Immunodeficiency Virus
GOEDERT
ANN INTERN MED 1986;105:309-610.
ABSTRACT  

Acquired Immunodeficiency Syndrome in Peru
ROJAS et al.
ANN INTERN MED 1986;105:465-466.
ABSTRACT  

HTLV-III ELISA Testing of Cadaveric Sera to Screen Potential Organ Transplant Donors
Pepose et al.
JAMA 1986;256:864-864.
ABSTRACT  

Laboratory and Epidemiologic Evaluation of an Enzyme Immunoassay for Antibodies to HTLV-III
Ward et al.
JAMA 1986;256:357-361.
ABSTRACT  

Prevalence of Antibodies to HTLV-I, -II, and -III in Intravenous Drug Abusers From an AIDS Endemic Region
Robert-Guroff et al.
JAMA 1986;255:3133-3137.
ABSTRACT  

Prevalence of Human T-Lymphotropic Virus Type III Antibodies Among Patients in Dialysis Programs at a University Hospital
MORRISON et al.
ANN INTERN MED 1986;104:805-807.
ABSTRACT  

Risk of Nosocomial Infection with Human T-Cell Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus in a Large Cohort of Intensively Exposed Health Care Workers
HENDERSON et al.
ANN INTERN MED 1986;104:644-647.
ABSTRACT  

Long-Term Seropositivity for Human T-Lymphotropic Virus Type III in Homosexual Men Without the Acquired Immunodeficiency Syndrome: Development of Immunologic and Clinical Abnormalities: A Longitudinal Study
MELBYE et al.
ANN INTERN MED 1986;104:496-500.
ABSTRACT  

Acquired Immunodeficiency Syndrome in Saudi Arabia: The American-Saudi Connection
Harfi and Fakhry
JAMA 1986;255:383-384.
ABSTRACT  

AIDS Health Education for Intravenous Drug Users
Friedman et al.
Health Educ Behav 1986;13:383-393.
ABSTRACT  

Epidemiology of Human T-Lymphotropic Virus Type III and the Risk of the Acquired Immunodeficiency Syndrome
BLATTNER et al.
ANN INTERN MED 1985;103:665-670.
ABSTRACT  

The Clinical Spectrum of the Acquired Immunodeficiency Syndrome: Implications for Comprehensive Patient Care
VOLBERDING
ANN INTERN MED 1985;103:729-733.
ABSTRACT  

HTLV-III Infection Among Health Care Workers: Association With Needle-Stick Injuries
Weiss et al.
JAMA 1985;254:2089-2093.
ABSTRACT  

HTLV-III Antibodies in US Army Blood Donors in West Germany
James and Morgenstern
JAMA 1985;254:1449-1449.
ABSTRACT  

Evidence for a 1980 HTLV-III Infection in a Currently Asymptomatic B Hemophiliac in Italy
Varnier et al.
JAMA 1985;254:1449-1450.
ABSTRACT  

Status Report on the Acquired Immunodeficiency Syndrome: Human T-Cell Lymphotropic Virus Type III Testing
Council on Scientific Affairs
JAMA 1985;254:1342-1345.
ABSTRACT  

The Acquired Immunodeficiency Syndrome in a Cohort of Homosexual Men: A Six-Year Follow-up Study
JAFFE et al.
ANN INTERN MED 1985;103:210-214.
ABSTRACT  

Screening for HTLV-III Antibodies: The Relation Between Prevalence and Positive Predictive Value and Its Social Consequences
Barry et al.
JAMA 1985;253:3395-3396.
ABSTRACT  

AIDS Serology Testing in Low- and High-Risk Groups
Carlson et al.
JAMA 1985;253:3405-3408.
ABSTRACT  

Potential Liability for Transfusion-Associated AIDS
Miller et al.
JAMA 1985;253:3419-3424.
ABSTRACT  

Autologous Blood Transfusion
Yomtovian
JAMA 1985;253:2491-2491.
ABSTRACT  

Development and Early Natural History of HTLV-III Antibodies in Persons With Hemophilia
Eyster et al.
JAMA 1985;253:2219-2223.
ABSTRACT  

Perspectives on the Future of AIDS
Quinn
JAMA 1985;253:247-249.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.